Comparisons of assessment pathways after abnormal mammography screening in Denmark, Norway, and Spain

Susanne Fogh Jørgensen*, Silje Sagstad, Javier Louro, Marta Román, Xavier Castells, Solveig Hofvind, Sisse Njor

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review


Purpose: To ensure high-quality screening programmes and effective utilization of resources, it is important to monitor how cancer detection is affected by different strategies performed at recall assessment. This study aimed to describe procedures performed at recall assessment and compare and evaluate the performance of the assessment in Denmark, Norway, and Spain in terms of screen-detected cancer (SDC) and interval cancer (IC) rates. Methods: We included women aged 50–69 years from Denmark, Norway, and Spain, who were recalled for assessment after screening mammography, and recorded all procedures performed during six months after diagnosis, and the timing of the procedures. Women were followed for two years and screen-detected and interval cancer, and sensitivity of recall was calculated and compared. Results: In total, data from 24,645 Danish, 30,050 Norwegian, and 41,809 Spanish women were included in the study. Most of the women had some assessment within 2 months in all three countries. SDC rates were higher in Denmark (0.57) and Norway (0.60) compared to Spain (0.38), as were the IC rates, i.e. 0.25 and 0.18 vs. 0.12, respectively. The sensitivity of the diagnostic follow-up was somewhat higher in Denmark (98.3%) and Norway (98.2%), compared to Spain (95.4%), but when excluding non-invasive assessment pathways, the sensitivities were comparable. Conclusion: This comparison study showed variation in the assessment procedures used in the three countries as well as the SDC and IC rates and the sensitivity of recall.

Original languageEnglish
JournalBreast Cancer Research and Treatment
Publication statusE-pub ahead of print - 29. Jan 2024
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2024, The Author(s).


  • Breast neoplasm
  • Mammography
  • Mass screening
  • Sensitivity


Dive into the research topics of 'Comparisons of assessment pathways after abnormal mammography screening in Denmark, Norway, and Spain'. Together they form a unique fingerprint.

Cite this